Cape Coral, FL
4Ever Young Cape Coral — GLP-1 therapy. Lab testing + nutrition counseling. Serving Cape Coral and Lee County. 4.6H
Need a clinic that prescribes Ozempic, Wegovy, or Mounjaro? Our directory lists 5 verified providers serving Cape Coral, Florida (233,025 residents · 29.6% adult obesity).
Each clinic below offers GLP-1 weight-loss medications including Ozempic, Wegovy, Mounjaro, and Zepbound. Compare ratings, services, and pricing — then book directly or via our partner directory at GLP1Maps.com.
Cape Coral, FL
4Ever Young Cape Coral — GLP-1 therapy. Lab testing + nutrition counseling. Serving Cape Coral and Lee County. 4.6H
1304 SE 8TH TER
Metabolic medicine provider specializing in medical weight management, bariatric care, and GLP-1 treatment in Cape Coral, Florida.
632 Del Prado Blvd N Ste 1, Cape Coral, FL 33909
Dr. Slavita Laies, M.D. is a endocrinology specialist in Cape Coral, Florida.
632 Del Prado Blvd N Ste 1, Cape Coral, FL 33909
Dr. Slavita Laies, M.D. is a endocrinology specialist in Cape Coral, Florida.
2838 Sw 30Th St, Cape Coral, FL 33914
Dr. Daniel Hanley, M.D. is a obesity medicine specialist in Cape Coral, Florida.
Full directory of verified providers on GLP1Maps.com
Get an AI Receptionist that books patients 24/7 — from GLP1Receptionist.com
Read Shep's Method — patient guide to GLP-1 success at ShepsMethod.com
Independent network of GLP-1 resources serving Cape Coral and patients across the U.S.
Choosing the right GLP-1 provider in Cape Coral matters. Look for clinics that offer:
GLP-1 receptor agonists work by mimicking a hormone that regulates appetite and blood sugar. The main options:
Florida Medicaid covers GLP-1 for diabetes; weight-loss generally not covered.
For state regulation info, see the Florida Medical Board.
Our directory lists 5 verified GLP-1 clinics in the Cape Coral area, with rankings based on patient reviews, services offered, and verified provider status.
Florida Medicaid covers GLP-1 for diabetes; weight-loss generally not covered.
Following the FDA's April 2026 503B ruling, compounded semaglutide and tirzepatide are no longer available from most U.S. pharmacies. Most clinics now prescribe FDA-approved Ozempic, Wegovy, Mounjaro, or Zepbound.